Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview
- 1 October 2024
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 31 (34) , 5535-5549
Abstract
: Protein tyrosine phosphatase 1B (PTP1B) has gained interest as a therapeutic target for type 2 diabetes and obesity. Besides metabolic signalling, PTP1B is a positive regulator of signalling pathways linked to ErbB2-induced breast tumorigenesis. Substan-tial evidence proves that its overexpression is involved in breast cancer, which suggests that selective PTP1B inhibition might be effective in breast cancer treatment. Therefore, huge research is being carried out on PTP1B inhibitors and their activity against breast cancer development. To date, only two PTP1B inhibitors, viz. ertiprotafib and tro-dusquemine, have entered clinical trials. The discovery of selective inhibitors of PTP1B could open a new avenue in breast cancer treatment. In this review, we provide an exten-sive overview on the involvement of PTP1B in breast cancer, its pathophysiology, with special attention on the discovery and development of various natural as well as synthetic PTP1B inhibitors. This study will provide significant information to the researchers de-veloping PTP1B inhibitors for breast cancer treatment.Keywords
Funding Information
- Department of Science and Technology, Government of India DST-SERB (SRG/2022/000006)
- Department of Science and Technology (DST), Government of India Departmental DST-FIST (SR/FST/LSI-656/2016)
This publication has 60 references indexed in Scilit:
- Design, synthesis, in silico and in vitro evaluation of thiophene derivatives: A potent tyrosine phosphatase 1B inhibitor and anticancer activityBioorganic & Medicinal Chemistry Letters, 2017
- PTP1B inhibitory and cytotoxic activities of triterpenoids from the aerial parts of Agrimonia pilosaMedicinal Chemistry Research, 2017
- TC-PTP and PTP1B: Regulating JAK–STAT signaling, controlling lymphoid malignanciesCytokine, 2016
- Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: Synthesis and in vitro biological evaluation. Part 1European Journal of Medicinal Chemistry, 2014
- PTP1B expression is an independent positive prognostic factor in human breast cancerBreast Cancer Research and Treatment, 2012
- Protein Tyrosine Phosphatase 1B Inhibitors: A Molecular Level Legitimate Approach for the Management of Diabetes MellitusMedicinal Research Reviews, 2010
- The two faces of PTP1B in cancerBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- A Brake Becomes an Accelerator: PTP1B—A New Therapeutic Target for Breast CancerCancer Cell, 2007
- A targeted molecular dynamics study of WPD loop movement in PTP1BBiochemical and Biophysical Research Communications, 2006
- Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian CancersGynecologic Oncology, 2003